Diamedica Therapeutics's total assets for Q4 2024 were $46.34M, a decrease of -11.76% from the previous quarter. DMAC total liabilities were $5.63M for the fiscal quarter, a 23.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.